Clinical Research Directory
Browse clinical research sites, groups, and studies.
Program to Avoid NSAIDs in Patients With Advanced Chronic Liver Disease
Sponsor: Parc de Salut Mar
Summary
This study aims to implement measures to avoid the use of NSAIDs or metamizole in patients with advanced chronic liver disease (ACLD) scheduled for major surgery, which are contraindicated due to increased risk of renal dysfunction such as acute kidney injury (AKI), clinical decompensation such as ascites, and bleeding.
Official title: Multidisciplinary Program to Avoid NSAIDs or Metamizole (HepatoAINEs Study) in Patients With Advanced Chronic Liver Disease Undergoing Major Surgery
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
84
Start Date
2023-04-01
Completion Date
2026-06-30
Last Updated
2025-12-03
Healthy Volunteers
No
Interventions
Multidisciplinary support program
The intervention includes guideline updates, automated alerts, and multidisciplinary support program (MSP) with collaboration among Digestive, Anesthesia, Surgery, and Pharmacy services to avoid the use of NSAIDs or metamizole in patients with cirrhosis.
Locations (1)
Hospital del Mar
Barcelona, Spain